Inhibition of lncRNA TCONS_00077866 Ameliorates the High Stearic Acid Diet-Induced Mouse Pancreatic β-Cell Inflammatory Response by Increasing miR-297b-5p to Downregulate SAA3 Expression

Diabetes. 2021 Oct;70(10):2275-2288. doi: 10.2337/db20-1079. Epub 2021 Jul 14.

Abstract

Long-term consumption of a high-fat diet increases the circulating concentration of stearic acid (SA), which has a potent toxic effect on β-cells, but the underlying molecular mechanisms of this action have not been fully elucidated. Here, we evaluated the role of long noncoding (lnc)RNA TCONS_00077866 (lnc866) in SA-induced β-cell inflammation. lnc866 was selected for study because lncRNA high-throughput sequencing analysis demonstrated it to have the largest fold-difference in expression of five lncRNAs that were affected by SA treatment. Knockdown of lnc866 by virus-mediated shRNA expression in mice or by Smart Silencer in mouse pancreatic β-TC6 cells significantly inhibited the SA-induced reduction in insulin secretion and β-cell inflammation. According to lncRNA-miRNAs-mRNA coexpression network analysis and luciferase reporter assays, lnc866 directly bound to miR-297b-5p, thereby preventing it from reducing the expression of its target serum amyloid A3 (SAA3). Furthermore, overexpression of miR-297b-5p or inhibition of SAA3 also had marked protective effects against the deleterious effects of SA in β-TC6 cells and mouse islets. In conclusion, lnc866 silencing ameliorates SA-induced β-cell inflammation by targeting the miR-297b-5p/SAA3 axis. lnc866 inhibition may represent a new strategy to protect β-cells against the effects of SA during the development of type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / pathology
  • Diabetes Mellitus, Type 2 / prevention & control
  • Diet, High-Fat / adverse effects
  • Down-Regulation / drug effects
  • Gene Expression Regulation / drug effects
  • HEK293 Cells
  • Humans
  • Inflammation / etiology
  • Inflammation / genetics
  • Inflammation / pathology
  • Inflammation / prevention & control*
  • Insulin Secretion / drug effects
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / metabolism
  • Insulin-Secreting Cells / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs / genetics
  • Palmitic Acid / adverse effects
  • Palmitic Acid / pharmacology
  • Pancreatitis / etiology
  • Pancreatitis / genetics
  • Pancreatitis / pathology
  • Pancreatitis / prevention & control
  • RNA, Long Noncoding / antagonists & inhibitors*
  • RNA, Long Noncoding / genetics
  • RNA, Small Interfering / pharmacology*
  • Serum Amyloid A Protein / genetics
  • Stearic Acids / adverse effects*
  • Stearic Acids / pharmacology

Substances

  • MIRN297a-2 microRNA, mouse
  • MicroRNAs
  • RNA, Long Noncoding
  • RNA, Small Interfering
  • Saa3 protein, mouse
  • Serum Amyloid A Protein
  • Stearic Acids
  • Palmitic Acid
  • stearic acid

Associated data

  • figshare/10.2337/figshare.14938800